Bajaj Healthcare Ltd Q1 Results FY27: Date, Revenue Estimates and What to Expect
- July 1, 2026
- Posted by: Kunal Singla
- Category: News
Bajaj Healthcare Ltd Q1 Results FY27 expected July-August 2026. CMP Rs.345 on NSE. Revenue estimate Rs.156-180 Cr. Analyst target Rs.338-386.
Bajaj Healthcare Ltd is expected to announce its Q1 FY27 (April to June 2026) financial results in July or August 2026. As of July 2026, the stock trades around Rs.345 on NSE with a market capitalisation of approximately Rs.1,181 Cr and a trailing P/E of 75.0x. This article covers Bajaj Healthcare Ltd’s Q1 FY27 revenue and PAT estimates, Q4 FY26 actual performance for context, key catalysts and risks, technical levels, and the 12-month share price target.
The healthcare and diagnostics sector is benefiting from rising inpatient volumes and improving average revenue per occupied bed in Q1 FY27.
This Bajaj Healthcare Ltd Q1 Results FY27 Q1 result preview covers Q1 expectations across estimates, catalysts, risks, technicals and the 12-month price target. Specifically, this article covers Bajaj Healthcare Ltd\’s Q1 FY27 analyst estimates, Q4 FY26 actual performance for context, key catalysts and risks to watch, technical levels, and the 12-month analyst share price target.
Get Free Investment Predictions and Bajaj Healthcare Ltd Research at Univest
About Bajaj Healthcare Ltd
Bajaj Healthcare Ltd (NSE: BAJAJHCARE) is a healthcare and diagnostics company listed on the National Stock Exchange and Bombay Stock Exchange. The Bajaj Healthcare Ltd Q1 Results FY27 is a must-watch Q1 result preview for investors. Q1 FY27 (April to June 2026) results will be a key data point for investors assessing the full-year FY27 earnings trajectory and sector positioning.
Bajaj Healthcare Ltd reported consolidated Revenue of Rs.153 Cr in Q4 FY26, providing the most recent sequential base against which Bajaj Healthcare Ltd Q1 Results FY27 Q1 expectations will be assessed. Q1 FY26 Revenue was Rs.149 Cr, forming the year-on-year comparison base for the Q1 FY27 estimate.
Bajaj Healthcare Ltd Q1 FY27 Estimates: What to Expect
Bajaj Healthcare Ltd Q1 FY27 revenue and PAT estimate, results date and 12-month analyst target
| Metric | Q1 FY27 Estimate | Q4 FY26 Actual | Context |
|---|---|---|---|
| Revenue | Rs.156-180 Cr | Rs.153 Cr | YoY estimate: +12.9% growth |
| PAT / Profitability | Rs.16-20 Cr | Rs.-23 Cr | Bottom-line estimate |
| Results Date | July-August 2026 (TBD) | – | Board meeting for Q1 FY27 approval |
| 12-Month Target | Rs.362-414 | – | Tracking |
Source: Q4 FY26 actuals from Screener.in; Bajaj Healthcare Ltd Q1 Results FY27 estimates (Q1 prediction by Uniresearch) are trailing-growth projections. July 2026. Estimates are projections only.
Key Catalysts to Watch in Bajaj Healthcare Ltd Q1 Results FY27
1. Inpatient Occupancy and ARPOB Growth
Rising inpatient occupancy and improving average revenue per occupied bed across tertiary and secondary hospitals are driving strong operating leverage in the healthcare sector. Analysts will scrutinise management commentary on this point closely during the Bajaj Healthcare Ltd Q1 Results FY27 earnings call. This is a core Q1 prediction metric watched by analysts.
2. Diagnostic Volume Recovery
Outpatient diagnostic and imaging volumes are recovering strongly, with preventive health check-up demand rising across urban markets. Analysts will scrutinise management commentary on this point closely during the Bajaj Healthcare Ltd Q1 Results FY27 earnings call. This is a core Q1 prediction metric watched by analysts.
3. Capacity Utilisation
Brownfield bed additions and acquisitions are improving capacity utilisation, while asset-light diagnostic expansion is adding high-margin revenue streams. Analysts will scrutinise management commentary on this point closely during the Bajaj Healthcare Ltd Q1 Results FY27 earnings call. This is a core Q1 prediction metric watched by analysts.
Key Risks for Bajaj Healthcare Ltd Q1 Results FY27
- Operating cost inflation from consumables and clinician compensation can squeeze EBITDA margins
- Seasonal variation in elective procedure volumes creates quarter-to-quarter earnings volatility
- Regulatory oversight on pricing and bed availability can restrict revenue optimisation
Track Bajaj Healthcare Ltd Q1 Results FY27 Fundamentals on Univest
Monitor Bajaj Healthcare Ltd Q1 Results FY27 Q1 expectations and live fundamentals, FII/DII activity, and sector comparison at Univest, a SEBI-Registered Investment Advisor.
Bajaj Healthcare Ltd Q4 FY26 Performance: Setting the Context
To understand Bajaj Healthcare Ltd Q1 Results FY27 Q1 expectations, it is important to contextualise Q4 FY26 (January to March 2026) performance. Bajaj Healthcare Ltd reported Revenue of Rs.153 Cr and PAT of Rs.-23 Cr in Q4 FY26. This performance provides the sequential base against which Bajaj Healthcare Ltd Q1 Results FY27 Q1 expectations will be assessed.
The Bajaj Healthcare Ltd Q1 Results FY27 revenue prediction of Rs.156-180 Cr in Revenue represents +12.9% year-on-year growth versus Q1 FY26 Revenue of Rs.149 Cr. Any material beat or miss relative to these estimates will likely drive meaningful stock price movement on the results day.
Technical Analysis: Bajaj Healthcare Ltd Share Price Levels
- Current Market Price: Rs.345 on NSE (July 1, 2026) , tracking Bajaj Healthcare Ltd Q1 Results FY27 ahead of results
- Trailing P/E: 75.0x | Market Cap: Rs.1,181 Cr
- For the latest 52-week high/low levels, track Bajaj Healthcare Ltd live on the NSE portal or Univest Screener
- Key resistance: Watch Q1 FY27 results beat/miss relative to the Rs.156-180 Cr revenue estimate as the near-term price catalyst
- The stock’s FY27 trajectory will be shaped by Q1 FY27 results and management guidance on full-year revenue growth
Download the Univest iOS App or Univest Android App to track Bajaj Healthcare Ltd’s live price, charts, and receive SEBI-backed research alerts.
Bajaj Healthcare Ltd Share Price Target: Analyst Estimates
Short-Term Target (3 to 6 Months)
In the near term, Bajaj Healthcare Ltd’s share price will be primarily driven by the Q1 Results FY27 Bajaj Healthcare Ltd Q1 Results FY27 outcome relative to estimates. A beat on Revenue or PAT, combined with positive management guidance for FY27, could drive the stock toward the higher end of the short-term range of Rs.338 to Rs.386. A miss or cautious guidance would test the lower end of this range.
12-Month Target (Uniresearch Estimate)
The 12-month price target for Bajaj Healthcare Ltd is estimated at Rs.362 to Rs.414, based on Uniresearch trailing-growth estimates of Rs.156-180 Cr. This implies potential upside from the current market price of Rs.345. Target achievement is contingent on Q1 Results FY27 meeting expectations and FY27 guidance being constructive.
Long-Term View (FY27 to FY28)
Longer-term, the Bajaj Healthcare Ltd Q1 Results FY27 Q1 result preview will anchor the FY27-FY28 outlook. Longer-term, Bajaj Healthcare Ltd’s share price trajectory will depend on sector growth trends, market share dynamics, management execution quality, and India’s overall macroeconomic environment. Investors with a 2 to 3 year horizon should evaluate the company on fundamental business quality, ROCE trends, free cash flow generation, and balance sheet health, rather than short-term quarterly movements.
What to Watch on Bajaj Healthcare Ltd Q1 Results FY27 Day
- Bajaj Healthcare Ltd Q1 Results FY27 Revenue and PAT numbers relative to Q1 Results FY27 estimates of Rs.156-180 Cr Revenue and Rs.16-20 Cr PAT, any material beat or miss will be the primary price driver
- Bajaj Healthcare Ltd Q1 Results FY27 management guidance: full-year FY27 Revenue and EBITDA margin direction
- Sector-specific operating metrics: inpatient occupancy and arpob growth and diagnostic volume recovery
- Any dividend announcement or capital allocation guidance
- Management commentary on macro headwinds including commodity costs, rupee movement, and demand outlook
Conclusion
Bajaj Healthcare Ltd’s Q1 Results FY27 are one of the key earnings events for India’s healthcare and diagnostics sector in the July to August 2026 results season. With the stock trading at Rs.345 and analyst targets pointing to Rs.362 to Rs.414 over 12 months per Uniresearch trailing-growth estimates, the Q1 FY27 outcome will be a critical catalyst for determining whether the stock achieves or delays its implied upside. Monitor the Univest research platform for Bajaj Healthcare Ltd Q1 Results FY27 real-time commentary, Q1 predictions and Q1 expectations post the Q1 result preview, post-result analysis, and updated price targets after results are declared.
Disclaimer: This article is for informational and educational purposes only and does not constitute investment advice or a stock recommendation. All estimates, analyst targets, and financial projections are based on Uniresearch trailing-growth analysis of Screener.in data as of July 2026 and are subject to change. Investing in stocks involves market risk. Please consult a SEBI-registered financial advisor before making any investment decisions. SEBI RA INH000013776.
Frequently Asked Questions on Bajaj Healthcare Ltd Q1 Results FY27
When is Bajaj Healthcare Ltd Q1 Results FY27 date?
Ans. The Bajaj Healthcare Ltd Q1 Results FY27 date has not been officially announced yet. Q1 FY27 (April to June 2026) results for NSE-listed companies are typically declared in July or August 2026. The board meeting notice will be published on the NSE and BSE filing portals. Check the NSE or BSE filing portal for the exact Bajaj Healthcare Ltd Q1 Results FY27 date once it is announced.
What is the Bajaj Healthcare Ltd Q1 FY27 revenue estimate?
Ans. The Bajaj Healthcare Ltd Q1 FY27 revenue estimate based on Uniresearch trailing-growth analysis is Rs.156 to Rs.180 Cr, representing +12.9% year-on-year growth against Q1 FY26 Revenue of Rs.149 Cr. Actual Q1 FY27 revenue may differ from this estimate.
What is the Bajaj Healthcare Ltd share price target?
Ans. The 12-month price target for Bajaj Healthcare Ltd is estimated at Rs.362 to Rs.414 based on Uniresearch trailing-growth estimates and current valuation. The stock trades at Rs.345 with a trailing P/E of 75.0x as of July 2026. Targets are subject to revision based on Q1 Results FY27 and FY27 guidance.
Is Bajaj Healthcare Ltd a good buy before Q1 FY27 results?
Ans. Investing ahead of quarterly results carries earnings risk. Stocks can fall sharply on results misses regardless of prior technical setup. The appropriate approach is to assess whether Bajaj Healthcare Ltd offers a good risk-reward at current levels of Rs.345 relative to both the bull case (beat plus positive guidance) and the bear case (miss plus cautious commentary). Consult a SEBI-registered financial advisor before making any investment decision.
What should I watch for in Bajaj Healthcare Ltd Q1 Results FY27?
Ans. Key metrics to monitor for Bajaj Healthcare Ltd Q1 Results FY27: Revenue performance versus the estimate of Rs.156 to Rs.180 Cr; PAT versus estimate; management guidance for FY27; inpatient occupancy and arpob growth progress; and management commentary on macro headwinds including Operating cost inflation from consumables and clinician compensation can squeeze EBITDA margins.
Where can I find Bajaj Healthcare Ltd Q1 Results FY27?
Ans. Bajaj Healthcare Ltd’s Q1 Results FY27 will be available on the BSE (bseindia.com) and NSE (nseindia.com) filing portals immediately after the board meeting. For real-time analysis, expert commentary, and updated price targets after results are declared, download the Univest app or visit the Univest website.
